IFNA17 and infection: The lack of improvement in outcomes from combination treatment might be due to the fact that both GRFT and IFN-α act to prevent subsequent rounds of infection by HCV; GRFT by blocking viral entry and IFN-α by suppressing the expression of HCV in infected cells [36].